United Therapeutics | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Amarin USD 119.52M 1.51M 2025-03
Ardelyx USD 48.65M 8.78M 2024-12
Baxter International USD 2.29B 530M 2025-03
Bayer EUR 4.56B 542M 2025-06
Biogen USD 2.76B 160.5M 2025-06
BioMarin Pharmaceutical USD 1.21B 601.78M 2025-06
Gilead Sciences USD 5.14B 2.78B 2025-06
GlaxoSmithKline GBP 3.6B 865M 2025-06
Halozyme Therapeutics USD 61.86M 114.47M 2025-06
Insmed USD 1.28B 881.08M 2025-06
Ionis Pharmaceuticals USD 297.3M 33.11M 2025-06
J&J USD 38.47B 32.35B 2025-03
Moderna USD 1.28B 344M 2025-06
Pfizer USD 1.64B 208M 2025-06
PTC Therapeutics USD 1.02B 1.01B 2025-06
Regeneron Pharmaceuticals USD 2B 1.09B 2025-06
Sarepta Therapeutics USD 510.6M 269.73M 2025-06
Teva Pharmaceutical Industries USD 2.16B 464M 2025-06
United Therapeutics USD 1.59B 306.8M 2025-06
Vertex Pharmaceuticals USD 6.38B 1.71B 2025-06


United Therapeutics Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.